Such alterations generate local structural defects, which in turn transfer to critical regions of the DBD, causing indirect loss of DNA binding.[6] Failure to bind DNA prevents p53-dependent transcription and hence inhibits p53-mediated tumor suppression. This evidence concerns the gene TP53 and neoplasm.